Secondary, AA, Amyloidosis.
Papa R, Lachmann HJ.
Rheum Dis Clin North Am. 2018 Nov;44(4):585-603. doi: 10.1016/j.rdc.2018.06.004. Epub 2018 Sep 7.
[Systemic secondary AA amyloidosis].
Cadiñanos J, Costa R, Trujillo D, Real de Asúa D.
Med Clin (Barc). 2015 Apr 8;144(7):324-30. doi: 10.1016/j.medcli.2014.05.024. Epub 2014 Jul 11.
Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
Gupta A, Bagri NK, Tripathy SK, Barwad A, Phulware RH, Hari P.
Rheumatol Int. 2020 Jan;40(1):153-159. doi: 10.1007/s00296-019-04363-z. Epub 2019 Jul 4.
Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review.
Karam S, Haidous M, Royal V, Leung N.
Kidney Int. 2023 Mar;103(3):473-484. doi: 10.1016/j.kint.2022.10.028. Epub 2022 Dec 9.
Systemic Amyloid A Amyloidosis Secondary to Xanthogranulomatous Pyelonephritis.
Habuka M, Nishikiori M, Oikawa C, Takahashi M, Sakamaki Y, Ogawa A, Miyajima N, Tanabe Y, Honma K, Wakaki K, Yamamoto S, Narita I.
Intern Med. 2024 Feb 15;63(4):593-599. doi: 10.2169/internalmedicine.1806-23. Epub 2023 Jul 5.
Macroglossia secondary to systemic amyloidosis: case report and literature review.
Xavier SD, Bussoloti IF, Müller H.
Ear Nose Throat J. 2005 Jun;84(6):358-61.
Amyloidosis of the Lung.
Khoor A, Colby TV.
Arch Pathol Lab Med. 2017 Feb;141(2):247-254. doi: 10.5858/arpa.2016-0102-RA.
Ankylosing spondylitis status and risk of secondary systemic amyloidosis: A two-sample mendelian randomization study.
Chen H, Yu L, Shao M.
Hum Immunol. 2024 Jan;85(1):110742. doi: 10.1016/j.humimm.2023.110742. Epub 2023 Dec 15.
Small Bowel Amyloidosis.
Bansal R, Syed U, Walfish J, Aron J, Walfish A.
Curr Gastroenterol Rep. 2018 Mar 26;20(3):11. doi: 10.1007/s11894-018-0616-y.
OCULAR MANIFESTATIONS OF SYSTEMIC AMYLOIDOSIS.
Reynolds MM, Veverka KK, Gertz MA, Dispenzieri A, Zeldenrust SR, Leung N, Pulido JS.
Retina. 2018 Jul;38(7):1371-1376. doi: 10.1097/IAE.0000000000001901.
